MED-EL is the world’s leading hearing implant company, dedicated to transforming the lives of individuals with hearing loss for over 30 years. Founded in 1977 by Dr. Ingeborg Hochmair, who pioneered the modern cochlear implant, MED-EL has expanded its global reach with over 2,900 professionals and products available in 137 countries. Their mission is to ensure that every person can experience the joy of sound, regardless of the type of hearing loss they face.

MED-EL offers a comprehensive portfolio of innovative hearing solutions, including cochlear implants, bone conduction systems, and middle ear implants, designed for reliability and superior performance. Their flagship devices, like the SONNET 3 and BONEBRIDGE, are tailored to meet diverse needs while providing ongoing support to recipients and their families throughout their hearing journeys. The company emphasizes partnerships with clinics and universities, focusing on research and development to improve the quality of life for over 1.5 billion individuals affected by hearing loss worldwide. Through initiatives like the AUDIOVERSUM science center, MED-EL showcases their commitment to advancing hearing health and technology.